Delivery Order SPE2DB22D2211-SPE2DB25FSCAZ
Award Date 8/1/25
Potential Completion Date 8/4/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $15,921.84 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pens with a completion date of August 11, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, reflecting the company's established role as a primary...
- The Defense Logistics Agency awarded a delivery order valued at $10,834.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $44,369.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside competitive award was performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used in the treatment of type 2 diabetes, and this delivery order represents one of many pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a delivery order valued at $7,198.85 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,577.37 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen (0.5 ml) on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a injectable medication used in diabetes management, and this order represents a routine...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $14,323.06 on August 13, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order...
- The Defense Logistics Agency awarded a $26,079.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,822.64 to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a prescription medication...
- The Defense Logistics Agency awarded a delivery order valued at $4,515.92 to AmerisourceBergen Drug Corp for Mounjaro 2.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-competitive delivery order represents a firm fixed-price pharmaceutical supply transaction to be performed at the vendor's Conshohocken, Pennsylvania location. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products...